Rapid Diagnostics for Traumatic Brain Injury (TBI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02836951 |
Recruitment Status :
Completed
First Posted : July 19, 2016
Last Update Posted : September 3, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Traumatic Brain Injury | Other: Withdrawal of blood |
Staff of the Neurosurgical ward is asked to report to the study coordinator all patients who are hospitalized due to a suspected brain injury. After an informed consent is received, the patient has been enrolled in the study and sample collection can be started. Plasma samples are taken by the TYKSlab personnel, and the other samples by the nurses in the Neurosurgical ward. The sampling will be organized so that all the samples from a patient are preferably collected at one event. Samples will stored in the TYKSlab at the temperature of -70 °C. Collection of a sufficient number of samples (patients) will take a few months, and subsequent analysis by the Sponsor a few months. All the activities will be done during the years 2016 to 2017.
When the samples of 24 subjects have been collected, they will be transferred to the Sponsor who will ship them further to the sub-contractors. The results received from the research laboratories will be evaluated by the scientist team at Medicortex Finland Oy. The results will be published in a scientific journal, when considered to be of high enough quality and impact.
Study Type : | Observational |
Actual Enrollment : | 24 participants |
Observational Model: | Case-Only |
Time Perspective: | Retrospective |
Official Title: | Rapid Chemical Diagnostics of Brain Injuries |
Actual Study Start Date : | September 2016 |
Actual Primary Completion Date : | January 31, 2017 |
Actual Study Completion Date : | January 31, 2017 |

Group/Cohort | Intervention/treatment |
---|---|
Patient
This group consists of patients that are hospitalized due to a head injury. Samples of blood, urine and plasma will taken from these subjects and the fluids will be analyzed for novel biomarkers using a biochemical assay.
|
Other: Withdrawal of blood
Withdrawal of blood |
Healthy controls
This group consists of healthy volunteers. Samples of blood, urine and plasma will taken from these subjects and the fluids will be analyzed for novel biomarkers using a biochemical assay.
|
Other: Withdrawal of blood
Withdrawal of blood |
- Presence of lectin-complexes in patients with TBI [ Time Frame: Two years ]There is a difference in the intensity of immuno-fluorescence readings between TBI patients and healthy controls. Different lectin bound complexes will be studied in body fluid samples collected from the patients (the trial is not following the patients nor is it intended to evaluate clinical outcome).
- Characterization of molecule structure of lectin-complexes [ Time Frame: Two years ]Molecular characterization of lectin-complexes by HPLC (high performance liquid chromatography) and MS (mass spectrometry) analysis. Samples retrieved from the patients are being analyzed comparing head injured to healthy controls. No follow-up of the patients and no clinical evaluation.
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patient is hospitalized because of a head trauma and suspected TBI.
- Age 18 or above. The subject (including the control subjects) must be an independent adult who is not under guardianship.
- The patient, or the next of kin in the case of an incompetent person, has signed the Informed consent. This concerns the control subjects, too.
- The samples can be collected during regular office hours.
- The patient needs lumbar puncture for treatment reasons. This is not a limiting criterion however. If it is difficult to find an adequate number of patients for lumbar puncture, CSF samples of some patients can be omitted after the study coordinator's consideration.
Exclusion Criteria:
- The subject has been found positive for HIV or hepatitis-B in the involved laboratory studies.
- The subject has a chronic mental disorder which is mentioned on the sickness insurance card.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02836951
Finland | |
Turku University Hospital (Tyks) | |
Turku, Finland |
Principal Investigator: | Jaakko Rinne, Professor | University of Turku |
Responsible Party: | Medicortex Finland Oy |
ClinicalTrials.gov Identifier: | NCT02836951 |
Other Study ID Numbers: |
T129/2016 |
First Posted: | July 19, 2016 Key Record Dates |
Last Update Posted: | September 3, 2020 |
Last Verified: | September 2020 |
Brain Injuries Brain Injuries, Traumatic Wounds and Injuries Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System |